The primary research interests of our department are regional anaesthesia, new applications of drugs, specific applications for and potential complications of newer Laryngeal Mask Airway Devices, and High Flow Nasal Oxygen applications.
Key Findings in 2018
- A Randomised Control Trial (RCT) is being finalised on a new regional anaesthetic technique: Transmuscular Quardratus Lumborum Block.
- Systematic reviews were published in the last two years on the effects of beta-blockade on analgesia, anaesthesia and postoperative nausea and vomiting.
- We are close to starting a cadaver study on Laryngeal Mask Airway pressure points.
- We are also progressing prospective trials into specific applications for Laryngeal Mask Airway devices.
- We are planning an RCT looking into advantages of high flow nasal oxygen in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) procedures.
Outcomes for the community
Regional anaesthesia can improve a patient’s postoperative experience by improving analgesia and reducing the effects of general anaesthesia. Beta-blockers can reduce intra-operative analgesic (opioid) and anaesthetic requirements whilst improving postoperative analgesia and reducing postoperative nausea and vomiting; again improving the patient’s experience. Improved Laryngeal Mask Airway applications can increase airway safety in specific patient groups.
Roelof Van Wijk (Director)
Vasanth Rao Kadam (Regional Anaesthesia)
Venkatesan Thiruvenkatarajan (Laryngeal Mask Airway and High Flow Nasal Oxygen)
Richard Watts (Beta-blockers and anaesthesia)